Sign In
Get Clay Free →

Suggestions

    Ileana Elder

    Branch Chief at CDER/FDA

    Professional Background

    Ileana Elder is a recognized expert in the realm of compliance activities concerning products regulated by the Food and Drug Administration (FDA). With an impressive career spanning over many years, Ileana has played pivotal roles within the FDA, significantly contributing to regulatory affairs for both pharmaceuticals and medical devices. Her expertise encompasses a range of essential compliance activities, including premarket and postmarket evaluations, recalls and shortages management, complaints investigations, corrective and preventive action (CAPA) establishment, and quality assurance measures in both environmental and clinical laboratory settings.

    Throughout her career, Ileana has served in multiple high-impact positions at the FDA, showcasing her commitment to regulatory excellence and effective product oversight. Currently, she holds the esteemed position of Branch Chief at FDA/CDER (Center for Drug Evaluation and Research). In this role, her leadership and strategic insight are crucial in ensuring that regulated products meet the stringent standards required for safety and effectiveness. Previously, she demonstrated her capability as the Division Director (Acting) at FDA/CDER/OC/ODSIR/DIER, further solidifying her prominence within the FDA hierarchy.

    Not only has Ileana made significant contributions within the FDA, but she has also positively influenced the broader field of regulatory sciences through her engagement with professional organizations. As a former faculty member at the Association for the Advancement of Medical Instrumentation (AAMI), she has shared her knowledge and skills with upcoming professionals in the industry, fostering a culture of learning and innovation. Her diverse roles have equipped her with a comprehensive understanding of the regulatory landscape, particularly regarding FDA compliance, and the requirements necessary to navigate it successfully.

    Education and Achievements

    Ileana's educational foundation is a crucial component of her exemplary professional journey. She earned her Bachelor of Science in Chemistry from the prestigious University of Puerto Rico, where she developed a solid base in the scientific methodologies that underpin effective regulatory practices. Following her undergraduate studies, she pursued her Ph.D. in Biomedical Sciences at the renowned University of Florida College of Medicine. This advanced education not only honed her research skills but also deepened her understanding of the biomedical innovations and products that are subject to FDA regulations.

    In addition to her academic credentials, Ileana's achievements stand out due to her extensive involvement in regulatory compliance. With specialties that include ISO 13485, FDA Good Manufacturing Practices (GMP) and Quality System (QS) inspections, and Clinical Laboratory Improvements Amendments (CLIA) audits, she has played an incredibly active role in maintaining the highest standards of product safety and efficacy.

    Her experience as a QA Coordinator at the State of Idaho further illustrates her commitment to quality assurance and regulation enforcement. Additionally, her history of conducting research during her tenure as a graduate assistant at the University of Florida and as an undergraduate researcher at the Universidad de Puerto Rico showcases her depth of experience in scientific inquiry and regulatory considerations.

    Key Achievements

    Among Ileana's key achievements are her successful contributions to numerous FDA inspections and audits, which have facilitated the compliance of medical devices and pharmaceuticals with FDA regulations. Her leadership as the Postmarket Team Leader at FDA/CDRH/OIR allowed her to spearhead significant initiatives aimed at improving postmarket surveillance and safety reporting mechanisms.

    In her capacity as a Regulatory Scientist/CSO at FDA/CDRH/OIR, Ileana was instrumental in developing regulatory pathways that enhanced market access for innovative medical devices and pharmaceuticals while ensured patient safety remained paramount. Her expertise in complaint investigations and CAPA processes has led to improved industry practices, thereby contributing to the greater safety of healthcare products available to consumers.

    Furthermore, Ileana's ongoing dedication to advancing the field of regulatory science is evident in her participation in numerous conferences and workshops where she presents her insights on compliance and quality assurance practices. Her extensive experience and knowledge not only inspire her colleagues but also serve as a valuable resource for stakeholders across the healthcare sector.

    In summary, Ileana Elder is a distinguished professional in the field of FDA compliance, characterized by her extensive educational background, dynamic career trajectory, and commitment to excellence in public health regulation. Her contributions to the FDA and the broader healthcare industry are notable and demonstrate her passion and dedication to ensuring the highest safety standards for medical products. Whether through her roles at various FDA divisions, involvement in medical instrument advancement organizations, or her educational background, Ileana’s work continues to make a lasting impact on the compliance landscape associated with critical biomedical products.

    Related Questions

    How did Ileana Elder develop expertise in FDA compliance activities?
    What is the significance of Ileana Elder's role as Branch Chief at FDA/CDER?
    Can you elaborate on Ileana Elder's experience with ISO 13485 in her regulatory work?
    How has Ileana Elder's educational background in Biomedical Sciences influenced her career at the FDA?
    In what ways has Ileana Elder contributed to improving postmarket surveillance for medical devices?
    I
    Add to my network

    Location

    Washington, District of Columbia, United States